AstraZeneca gets approval to import breast cancer treatment drug in India
The India approval is based on a global, head-to-head, randomised, open-label, registrational Phase III trial of DESTINY Breast 03.
The India approval is based on a global, head-to-head, randomised, open-label, registrational Phase III trial of DESTINY Breast 03.
